14.46
price up icon0.49%   0.07
 
loading

Biohaven Ltd (BHVN) 最新ニュース

pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

Biohaven stock hits 52-week low at 14.32 USD By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Biohaven (BHVN) Price Target Lowered by JPMorgan to $55 | BHVN S - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Biohaven (BHVN) Target Price Lowered by JP Morgan Analyst | BHVN Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Biohaven (BHVN) Price Target Lowered by JPMorgan to $55 | BHVN Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Biohaven price target lowered to $55 from $68 at JPMorgan - TipRanks

Jun 18, 2025
pulisher
Jun 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. ... - Bluefield Daily Telegraph

Jun 15, 2025
pulisher
Jun 12, 2025

Biohaven Insiders Added US$6.28m Of Stock To Their Holdings - Yahoo Finance

Jun 12, 2025
pulisher
Jun 11, 2025

Investigation Underway: Biohaven Ltd. (BHVN)Contact Levi & Korsinsky Over Securities Law Violations - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 11, 2025

New Haven-based bioscience firms Bexorg, Biohaven agree to collaborate - Hartford Business Journal

Jun 11, 2025
pulisher
Jun 11, 2025

BHVN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Biohaven Ltd. - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 10, 2025

Biohaven (BHVN) Teams Up with Bexorg for CNS Disorder Research C - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Kalkine : Biohaven Ltd Shift Amid Sector Moves and Earnings Per Share Focus - Kalkine Media

Jun 10, 2025
pulisher
Jun 10, 2025

Biohaven, Bexorg Collaborate to Develop CNS Therapies - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Biohaven (BHVN) Teams Up with Bexorg for CNS Disorder Research Collaboration | BHVN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Bexorg announces multi-program research collaboration with Biohaven - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

Bexorg Announces Research Collaboration with Biohaven - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Purchased by Parallel Advisors LLC - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Levi & Korsinsky Investigates Possible Securities Fraud by Biohaven Ltd. (BHVN) - ACCESS Newswire

Jun 09, 2025
pulisher
Jun 07, 2025

Fraud Investigation: Levi & Korsinsky Investigates Biohaven Ltd. (BHVN) on Behalf of Shareholders - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 06, 2025

Levi & Korsinsky Investigating Whether Biohaven Ltd. (BHVN) Misled InvestorsSecurities Law Violations Possible - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - GlobeNewswire Inc.

Jun 06, 2025
pulisher
Jun 05, 2025

Ongoing Biohaven Ltd. (BHVN) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 04, 2025

Biohaven Ltd. Highlights Strategic Focus in Investor Presentation - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Biohaven Ltd. (BHVN) - ACCESS Newswire

Jun 04, 2025
pulisher
Jun 04, 2025

Sector Update: Health Care - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Biohaven Shares Rise on Drug Pipeline Update With Two Near-Market Candidates - marketscreener.com

Jun 04, 2025
pulisher
Jun 03, 2025

Shareholders Alert: Investigation Into Biohaven Ltd. (BHVN)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 01, 2025

Biohaven Ltd.: Promising Pipeline and Undervaluation Justify Buy Rating - TipRanks

Jun 01, 2025
pulisher
Jun 01, 2025

Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy” - Insider Monkey

Jun 01, 2025
pulisher
May 31, 2025

Jim Cramer’s Thoughts on These 10 Stocks - Insider Monkey

May 31, 2025
pulisher
May 31, 2025

Biohaven Lands Major $600 Million Deal With Oberland Capital - Finimize

May 31, 2025
pulisher
May 31, 2025

How To Trade (BHVN) - news.stocktradersdaily.com

May 31, 2025
pulisher
May 31, 2025

Biohaven Ltd. Receives Buy Rating Amidst Promising Developments and Strategic Advancements - TipRanks

May 31, 2025
pulisher
May 31, 2025

Biohaven stock hits 52-week low at $14.36 amid market challenges By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

Morgan Stanley maintains Biohaven stock with $63 target - Investing.com Australia

May 30, 2025
pulisher
May 30, 2025

BHVN Investor Notice: Levi & Korsinsky Investigates Biohaven Ltd. for Securities Law Violations - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Biohaven stock hits 52-week low at $14.36 amid market challenges - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright maintains Buy on Biohaven stock, $54 price target - Investing.com Australia

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright maintains Buy on Biohaven stock, $54 price target By Investing.com - Investing.com India

May 30, 2025
pulisher
May 30, 2025

Biohaven Ltd. Receives Buy Rating from Douglas Tsao Amid Promising R&D Advancements and Strategic Developments - TipRanks

May 30, 2025
pulisher
May 29, 2025

Investors in Biohaven Ltd. (BHVN) Warned of Potential Securities FraudContact Levi & Korsinsky Today - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Cowen reiterates Buy on Biohaven stock, maintains $75 target By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Biohaven Ltd. Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor - MarketScreener

May 29, 2025
pulisher
May 29, 2025

Cowen reiterates Buy on Biohaven stock, maintains $75 target - Investing.com

May 29, 2025
pulisher
May 29, 2025

Biohaven (BHVN) Commences Innovative Phase 2/3 Parkinson's Drug - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Biohaven initiates global Phase 2/3 study of BHV-8000 - TipRanks

May 29, 2025
pulisher
May 29, 2025

Biohaven (BHVN) Commences Innovative Phase 2/3 Parkinson's Drug Trial | BHVN Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN' - StreetInsider

May 29, 2025
$21.16
price down icon 1.86%
$34.86
price down icon 0.14%
$20.56
price up icon 1.98%
$102.68
price up icon 3.24%
$106.53
price up icon 2.04%
biotechnology ONC
$247.08
price down icon 2.25%
大文字化:     |  ボリューム (24 時間):